12/09/2024
2:18 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
3:51 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:55 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
2:23 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:26 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:15 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:19 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/29/2024
2:49 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
2:54 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
2:35 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
5:33 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
3:19 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
7:49 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2024
7:52 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:15 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
2:29 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:26 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
2:42 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:34 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:37 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:45 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:30 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:33 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:02 PM | Moderna (Issuer)
Rubenstein David M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
6:05 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
10:44 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:34 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:28 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad) To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems.
For its next act, AI is going to help save lives.
Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the |
06/21/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:28 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
11:45 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:01 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:41 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:26 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
2:16 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
4:27 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:20 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
2:36 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:11 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:36 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:34 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:12 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
2:12 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:14 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:27 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
12:41 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
3:03 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:43 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:51 PM | LANGER ROBERT (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:54 PM | Horning Sandra (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:57 PM | Moderna (Issuer)
Tallett Elizabeth E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:59 PM | Moderna (Issuer)
SAGAN PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:02 PM | Moderna (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:42 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:21 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:17 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:23 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
9:58 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad) To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems.
For its next act, AI is going to help save lives.
Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the |
04/10/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Moderna (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024
3:09 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:32 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free MRNA Stock Alerts